Real-Life Clinical Practice with Sorafenib in Advanced Hepatocellular Carcinoma: A Single-Center Experience

Treatment of Advanced Hepatocellular Carcinoma with Emphasis on Hepatic Arterial Infusion Chemotherapy and Molecular Targeted Therapy

(2012) Masatoshi Kudo   Liver Cancer

Chemoembolization in Patients with Hepatocellular Carcinoma

(2012) Riccardo Lencioni   Liver Cancer

Epidemiology and Surveillance of Hepatocellular Carcinoma

(2012) Do Young Kim et al.   Liver Cancer

Signaling Pathway and Molecular-Targeted Therapy for Hepatocellular Carcinoma

(2011) Masatoshi Kudo   DIGESTIVE DISEASES

Management of Hepatocellular Carcinoma in Japan: Consensus-Based Clinical Practice Guidelines Proposed by the Japan Society of Hepatology (JSH) 2010 Updated Version

(2011) Masatoshi Kudo et al.   DIGESTIVE DISEASES

Response Evaluation Criteria in Cancer of the Liver (RECICL) proposed by the Liver Cancer Study Group of Japan (2009 Revised Version)

(2010) Masatoshi Kudo et al.   HEPATOLOGY RESEARCH

Current status of molecularly targeted therapy for hepatocellular carcinoma: clinical practice

(2010) Masatoshi Kudo   International Journal of Clinical Oncology

Positioning of a Molecular-Targeted Agent, Sorafenib, in the Treatment Algorithm for Hepatocellular Carcinoma and Implication of Many Complete Remission Cases in Japan

(2010) Masatoshi Kudo et al.   ONCOLOGY

Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma

(2010) Riccardo Lencioni et al.   SEMINARS IN LIVER DISEASE

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

(2008) Ann-Lii Cheng et al.   LANCET ONCOLOGY

Sorafenib in Advanced Hepatocellular Carcinoma

(2008) Josep M. Llovet et al.   NEW ENGLAND JOURNAL OF MEDICINE